Page last updated: 2024-08-23

pergolide and Cirrhosis

pergolide has been researched along with Cirrhosis in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (6.25)18.2507
2000's15 (93.75)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andersohn, F; Garbe, E1
Berendse, H; Bloem, BR; Boon, AJ; de Koning-Tijssen, MA; Hovestadt, A; Nijssen, PC; van Hilten, JJ; van Laar, T; Weber, WE1
Caveliers, V; Cosyns, B; Degaillier, C; Droogmans, S; Franken, PR; Garbar, C; Hernot, S; Lahoutte, T; Pipeleers-Marichal, M; Roosens, B; Schoors, D; Van Camp, G; Weytjens, C1
Bhattacharyya, S; Davar, J; Mikhailidis, DP; Schapira, AH1
Lanier, WL1
Bagheri, H; Montastruc, JL; Pathak, A1
Agarwal, P; Fahn, S; Frucht, SJ1
Horowski, R; Jähnichen, S; Pertz, HH1
Basu, S; Chaudhuri, KR; Dhawan, V; Jackson, G; Odin, P1
Bagheri, H; Montastruc, JL; Pathak, A; Rascol, O1
Roth, J; Růzicka, E; Ulmanová, O1
Fuhrmann, JT; Junghanns, S; Koch, R; Oelwein, C; Reichmann, H; Simonis, G; Storch, A; Strasser, RH1
Grandas, F1
Chihara, N; Hayakawa, M; Nakase, H; Shiio, Y; Yoshimura, M1
Dick, DJ; Pilling, JB; Shaunak, S; Wilkins, A1
Danoff, SK; Flynn, JA; Grasso, ME; Terry, PB1

Reviews

2 review(s) available for pergolide and Cirrhosis

ArticleYear
Drug-induced fibrotic valvular heart disease.
    Lancet (London, England), 2009, Aug-15, Volume: 374, Issue:9689

    Topics: Antiparkinson Agents; Appetite Depressants; Cabergoline; Dexfenfluramine; Dopamine Agonists; Drug Monitoring; Ergolines; Ergotamine; Fenfluramine; Fibrosis; Heart Valve Diseases; Heart Valves; Humans; Methysergide; Migraine Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Patient Selection; Pergolide; Receptors, Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Vasoconstrictor Agents

2009
[Cardiac valvulopathy and dopamine agonist].
    Neurologia (Barcelona, Spain), 2007, Volume: 22, Issue:10

    Topics: Antiparkinson Agents; Biomedical Research; Dopamine Agonists; Fibrosis; Heart Valve Diseases; Heart Valves; Humans; Pergolide

2007

Trials

1 trial(s) available for pergolide and Cirrhosis

ArticleYear
Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: a reader-blinded monocenter echocardiography study.
    Movement disorders : official journal of the Movement Disorder Society, 2007, Jan-15, Volume: 22, Issue:2

    Topics: Benzothiazoles; Cabergoline; Dopamine Agonists; Double-Blind Method; Echocardiography; Ergolines; Female; Fibrosis; Heart Valve Diseases; Humans; Hypertrophy, Left Ventricular; Indoles; Male; Middle Aged; Mitral Valve Insufficiency; Parkinson Disease; Pergolide; Pramipexole; Severity of Illness Index; Tricuspid Valve Insufficiency

2007

Other Studies

13 other study(ies) available for pergolide and Cirrhosis

ArticleYear
Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists.
    Movement disorders : official journal of the Movement Disorder Society, 2009, Jan-15, Volume: 24, Issue:1

    Topics: Aged; Aged, 80 and over; Apomorphine; Benzothiazoles; Bromocriptine; Cabergoline; Databases, Factual; Dopamine Agonists; Endomyocardial Fibrosis; Ergolines; Female; Fibrosis; Heart Valve Diseases; Humans; Indoles; Male; Middle Aged; Pergolide; Pericarditis; Pleural Diseases; Pramipexole; Pulmonary Fibrosis; Retroperitoneal Fibrosis; Tetrahydronaphthalenes; Thiophenes; United States

2009
[Pergolide use and heart valve fibrosis. Yearly control in patients with Parkinson disease who use pergolide].
    Nederlands tijdschrift voor geneeskunde, 2009, Jan-17, Volume: 153, Issue:3

    Topics: Dopamine Agonists; Echocardiography; Fibrosis; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide; Risk Factors

2009
Cyproheptadine prevents pergolide-induced valvulopathy in rats: an echocardiographic and histopathological study.
    American journal of physiology. Heart and circulatory physiology, 2009, Volume: 296, Issue:6

    Topics: Animals; Blood Pressure; Body Weight; Cyproheptadine; Dopamine Agonists; Drug Interactions; Echocardiography; Fibrosis; Heart Valve Diseases; Heart Valves; Male; Myocytes, Cardiac; Pergolide; Rats; Rats, Wistar; Serotonin Antagonists

2009
Additional insights into pergolide-associated valvular heart disease.
    Mayo Clinic proceedings, 2003, Volume: 78, Issue:6

    Topics: Adverse Drug Reaction Reporting Systems; Dopamine Agonists; Evidence-Based Medicine; Fibrosis; Heart Valve Diseases; Humans; Incidence; Pergolide; Registries; Serotonin

2003
[Pergolide treatment and cardiac valve pathology: the continuing saga of ergotamine-induced fibrosis].
    Revue neurologique, 2004, Volume: 160, Issue:1

    Topics: Dopamine Agonists; Ergotamine; Fibrosis; Heart Diseases; Heart Valve Diseases; Humans; Pergolide; Vasoconstrictor Agents

2004
Diagnosis and management of pergolide-induced fibrosis.
    Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:6

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Biopsy, Needle; Bronchi; Female; Fibrosis; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Pergolide; Pleural Diseases; Retroperitoneal Fibrosis; Tomography, X-Ray Computed

2004
Fibrotic valvular heart disease is not related to chemical class but to biological function: 5-HT2B receptor activation plays crucial role.
    Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:12

    Topics: Dopamine Agents; Fibroblasts; Fibrosis; Heart Valve Diseases; Humans; Myoblasts; Parkinson Disease; Pergolide; Receptors, Serotonin

2004
Valvular heart disease and fibrotic reactions may be related to ergot dopamine agonists, but non-ergot agonists may also not be spared.
    Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:12

    Topics: Aortic Valve; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Fibrosis; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide

2004
Dopaminagonists and fibrotic valvular heart disease: further considerations.
    Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:12

    Topics: Dopamine Agonists; Fibrosis; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide

2004
[Organ changes induced by ergot derivative dopamine agonist drugs: time to change treatment guidelines in Parkinson's disease?].
    Casopis lekaru ceskych, 2005, Volume: 144, Issue:2

    Topics: Aged; Dopamine Agonists; Female; Fibrosis; Humans; Male; Middle Aged; Parkinson Disease; Pergolide

2005
[Low dose pergolide induced systemic edema and pleural effusion in a patient with Parkinson's disease].
    Rinsho shinkeigaku = Clinical neurology, 2008, Volume: 48, Issue:2

    Topics: Aged; Edema; Female; Fibrosis; Heart Valves; Humans; Parkinson Disease; Pergolide; Peritoneum; Pleura; Pleural Effusion; Severity of Illness Index

2008
Pericardial, retroperitoneal, and pleural fibrosis induced by pergolide.
    Journal of neurology, neurosurgery, and psychiatry, 1999, Volume: 66, Issue:1

    Topics: Aged; Antiparkinson Agents; Fibrosis; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Pericardium; Pleura; Retroperitoneal Fibrosis

1999
Pleuropulmonary disease due to pergolide use for restless legs syndrome.
    Chest, 2001, Volume: 120, Issue:1

    Topics: Aged; Dopamine Agonists; Fibrosis; Humans; Male; Pergolide; Pleural Diseases; Pleural Effusion; Pulmonary Fibrosis; Restless Legs Syndrome

2001